CD9 is associated with leukemia inhibitory factor-mediated maintenance of embryonic stem cells

被引:91
作者
Oka, M
Tagoku, K
Russell, TL
Nakano, Y
Hamazaki, T
Meyer, EM
Yokota, T
Terada, N [1 ]
机构
[1] Univ Florida, Coll Med, Dept Pathol, Program Stem Cell Biol,Shands Canc Ctr, Gainesville, FL 32610 USA
[2] Univ Florida, Coll Med, Dept Pharmacol, Gainesville, FL 32610 USA
[3] Univ Tokyo, Inst Med Sci, Dept Stem Cell Regulat, Tokyo 1088639, Japan
关键词
D O I
10.1091/mbc.02-01-0600
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mouse embryonic stem (ES) cells can proliferate indefinitely in an undifferentiated state in the presence of leukemia inhibitory factor (LIF), or differentiate into all three germ layers upon removal of this factor. To determine cellular factors associated with self-renewal of undifferentiated ES cells, we used polymerase chain reaction-assisted cDNA subtraction to screen genes that a-re expressed in undifferentiated ES cells and down-regulated after incubating these cells in a differentiation medium without LIF for 48 h. The mRNA expression of a tetraspanin transmembrane protein, CD9, was high in undifferentiated ES cells and decreased shortly after cell differentiation. An immunohistochemical analysis confirmed that plasma membrane-associated CD9 was expressed in undifferentiated ES cells but low in the differentiated cells. Addition of LIF to differentiating ES cells reinduced mRNA expression of CD9, and CD9 expression was accompanied with a reappearance of undifferentiated ES cells. Furthermore, activation of STAT3 induced the expression of CD9, indicating the LIF/STAT3 pathway is critical for maintaining CD9 expression. Finally, addition of anti-CD9 antibody blocked ES cell colony formation and reduced cell viability. These results indicate that CD9 may play a role in LIF-mediated maintenance of undifferentiated ES cells.
引用
收藏
页码:1274 / 1281
页数:8
相关论文
共 65 条
[1]   Stromal cell CD9 regulates differentiation of hematopoietic stem/progenitor cells [J].
Aoyama, K ;
Oritani, K ;
Yokota, T ;
Ishikawa, J ;
Nishiura, T ;
Miyake, K ;
Kanakura, Y ;
Tomiyama, Y ;
Kincade, PW ;
Matsuzawa, Y .
BLOOD, 1999, 93 (08) :2586-2594
[2]   Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins) [J].
Berditchevski, F ;
Zutter, MM ;
Hemler, ME .
MOLECULAR BIOLOGY OF THE CELL, 1996, 7 (02) :193-207
[3]   New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2 [J].
Botquin, V ;
Hess, H ;
Fuhrmann, G ;
Anastassiadis, C ;
Gross, MK ;
Vriend, G ;
Schöler, HR .
GENES & DEVELOPMENT, 1998, 12 (13) :2073-2090
[4]   FORMATION OF GERM-LINE CHIMERAS FROM EMBRYO-DERIVED TERATOCARCINOMA CELL-LINES [J].
BRADLEY, A ;
EVANS, M ;
KAUFMAN, MH ;
ROBERTSON, E .
NATURE, 1984, 309 (5965) :255-256
[5]  
Buckley CD, 1996, J CELL SCI, V109, P437
[6]   Role of the Lewisx glycan determinant in corneal epithelial cell adhesion and differentiation [J].
Cao, ZY ;
Zhao, Z ;
Mohan, R ;
Alroy, J ;
Stanley, P ;
Panjwani, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (24) :21714-21723
[7]   Adhesion receptors on haematopoietic progenitor cells [J].
Chan, JYH ;
Watt, SM .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (03) :541-557
[8]   Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival [J].
Denhardt, DT ;
Noda, M ;
O'Regan, AW ;
Pavlin, D ;
Berman, JS .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (09) :1055-1061
[9]   HIGH EXPRESSION OF STATHMIN IN MULTIPOTENTIAL TERATOCARCINOMA AND NORMAL EMBRYONIC-CELLS VERSUS THEIR EARLY DIFFERENTIATED DERIVATIVES [J].
DOYE, V ;
KELLERMANN, O ;
BUCCARON, MH ;
SOBEL, A .
DIFFERENTIATION, 1992, 50 (02) :89-96
[10]  
EGGENS I, 1989, J BIOL CHEM, V264, P9476